Introduction: With the current coronavirus disease 2019 (COVID‐19) pandemic, concerns
have been raised about the risk to children with inflammatory bowel diseases (IBD). We aimed …

Background & Aims Studies have shown decreased response to coronavirus disease 2019 (COVID-19)
vaccinations in some populations. In addition, it is possible that vaccine-…

Introduction: There is increasing interest in measuring mucosal inflammation in Crohn disease
(CD), but there are minimal data correlating the Pediatric Crohn's Disease Activity Index (…

Background & Aims Bowel healing is an important goal of therapy for patients with Crohn’s
disease (CD). Although there have been many studies of mucosal healing, transmural …

Background Scarce data are available on the use of vedolizumab in children with inflammatory
bowel disease (IBD). We aimed to evaluate the safety, effectiveness, and dosing of …

Background & Aims Cross-sectional imaging is important in the assessment of transmural
inflammation in Crohn’s disease (CD). Small bowel involvement is often more extensive in …

Background Alterations in the microbiome have been postulated to drive inflammation in IBD.
In this pilot randomized controlled trial, we evaluated the effectiveness of quadruple …

Background Before embarking on administrative research, validated case ascertainment
algorithms must be developed. We aimed at developing algorithms for identifying inflammatory …

Objectives We aimed to review the literature on fatigue in pediatric inflammatory bowel diseases
(PIBD), to explore how it is measured, and approximate its rate in an inception pediatric …

Background There are currently no nationwide data on the epidemiology of inflammatory
bowel diseases (IBD) in Israel. We aimed to determine the population-based epidemiological …